IDEXX Laboratories Q3 2025 Financial Report

These two sources provide a detailed financial overview of IDEXX Laboratories, Inc., primarily focusing on the quarterly report on Form 10-Q for the period ended September 30, 2025. The documents contain comprehensive condensed consolidated financial statements, including income, balance sheets, and cash flows, along with extensive management discussion and analysis of the company’s financial condition and results of operations. Key areas of focus include revenue growth, segmented by CAG (Companion Animal Group), Water, and LPD (Livestock, Poultry, and Dairy), as well as non-GAAP financial measures like organic revenue growth and comparable earnings per share (EPS). Furthermore, the reports address liquidity and capital resources, market risks related to foreign currency exchange rates, and the company's debt structure, including compliance with the sole financial covenant, the consolidated leverage ratio.